Impulsive and aggressive behaviors are both modulated by serotonergic signaling, specifically through the serotonin 1B receptor (5-HT1BR). 5-HT1BR knockout mice show increased aggression and impulsivity, and 5-HT1BR polymorphisms are associated with aggression and drug addiction in humans. To dissect the mechanisms by which the 5-HT1BR affects these phenotypes, we developed a mouse model to spatially and temporally regulate 5-HT1BR expression. Our results demonstrate that forebrain 5-HT1B heteroreceptors expressed during an early postnatal period contribute to the development of the neural systems underlying adult aggression. However, distinct heteroreceptors acting during adulthood are involved in mediating impulsivity. Correlating with the impulsivity, dopamine in the nucleus accumbens is elevated in the absence of 5-HT1BRs and normalized following adult rescue of the receptor. Overall, these data show that while adolescent expression of 5-HT1BRs influences aggressive behavior, a distinct set of 5-HT1B receptors modulates impulsive behavior during adulthood.
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SUMMARY
Impulsive and aggressive behaviors are both modulated by serotonergic signaling, specifically through the serotonin 1B receptor (5-HT1BR). 5-HT1BR knockout mice show increased aggression and impulsivity, and 5-HT1BR polymorphisms are associated with aggression and drug addiction in humans. To dissect the mechanisms by which the 5-HT1BR affects these phenotypes, we developed a mouse model to spatially and temporally regulate 5-HT1BR expression. Our results demonstrate that forebrain 5-HT1B heteroreceptors expressed during an early postnatal period contribute to the development of the neural systems underlying adult aggression. However, distinct heteroreceptors acting during adulthood are involved in mediating impulsivity. Correlating with the impulsivity, dopamine in the nucleus accumbens is elevated in the absence of 5-HT1BRs and normalized following adult rescue of the receptor. Overall, these data show that while adolescent expression of 5-HT1BRs influences aggressive behavior, a distinct set of 5-HT1B receptors modulates impulsive behavior during adulthood.
INTRODUCTION
Impulsivity and aggression are related behavioral phenotypes that are both modulated by serotonin (Coccaro, 1992) . Although highly comorbid, frequently affected by the same manipulations, and often referred to as a single trait-impulsive-aggression (Balleine and Dickinson, 1998; Dalley et al., 2002) -they are distinct behavioral constructs with potentially discrete underlying neural systems (García-Forero et al., 2009) . Little is known about how serotonin modulates the underlying neural circuits or whether there is a developmental contribution to these effects. Studies in humans and a variety of animal models suggest that increased serotonergic signaling during development is associated with increased aggressive and impulsive behavior (Cases et al., 1995; Dennis et al., 2013; Ricci and Melloni, 2012) . However, the reverse is true in adulthood-serotonin levels are inversely correlated with aggression, impulsivity, and risky behavior (Audero et al., 2013; Brown et al., 1979; Crockett et al., 2009; Higley and Linnoila, 1997) . These differential effects may be mediated by distinct underlying neural circuits and/or different sensitive periods. Since aggression and impulsivity are intermediate phenotypes in a number of mental health disorders, including addictive disorders, antisocial personality disorder, and attention deficit disorder, understanding the underlying neural circuit(s) may help develop more effective treatments.
The serotonin 1B receptor (5-HT1BR) is implicated in both aggressive and impulsive behavior. In humans, polymorphisms in 5-HT1BR have been linked to impulsive aggression, anger, conduct disorder, and other disorders that have dysregulated impulse control such as substance use disorders (Cao et al., 2013; Conner et al., 2010; Jensen et al., 2009; Zouk et al., 2007) . In mouse models, 5-HT1BR knockout (KO) mice are highly aggressive and impulsive. Specifically, conspecific male territorial aggression is increased-KO residents attack intruders more often and with a shorter latency (Saudou et al., 1994) . KO mice also exhibit increased cocaine self-administration and low response inhibition (Pattij et al., 2003; Rocha et al., 1998) . While these studies implicate 5-HT1BR in modulating adult aggressive and impulsive behavior, they do not address the potential developmental impact of 5-HT1BR, nor delineate the underlying neural circuits.
The 5-HT1BR is a G protein coupled receptor (GPCR) that inhibits neurotransmitter release from both serotonergic and non-serotonergic neurons (reviewed in Sari, 2004) . The ''autoreceptor'' population of 5-HT1BRs is located on the axon terminals of serotonergic cells, thus affecting the release of serotonin in many brain regions. The ''heteroreceptor'' population of 5-HT1BRs is located on nerve terminals of neurons from other neurotransmitter systems including glutamate, GABA, dopamine, and acetylcholine (Boschert et al., 1994; Pazos et al., 1985) . In all cases, the receptor is synthesized in the cell body and transported to pre-synaptic terminals, where it is coupled to either the G protein Gi or Go (Boschert et al., 1994) and inhibits neurotransmitter release (Mizutani et al., 2006) .
To dissect the role of the 5-HT1BR in mediating aggressive and impulsive behavior, we have generated a targeted transgenic mouse that permits temporal and spatial regulation of 5-HT1BR (Figure 1) . A floxed tetracycline operator (tetO)-5-HT1B cDNA cassette has been inserted in place of the endogenous coding region of htr1b to generate Htr1b tetO/tetO mice (referred to as tetO1B). Crossing tetO1B mice to transgenic mice expressing either the tetracycline-dependent transcriptional silencer (tTS) or Cre recombinase allows knockdown of htr1b expression. Here we have used the ubiquitous b-actin promoter and two tissue-specific promoters-CaMKIIa and Pet1-to drive 5-HT1BR knockdown of all receptors, forebrain heteroreceptors, or autoreceptors, respectively. Our data show that ubiquitous knockdown results in aggressive and impulsive behavior (in keeping with the original knockout phenotype). However, rescue of receptor expression in adulthood with doxycycline reverses the impulsive, but not the aggressive, phenotype. This suggests that adult aggression can be determined early during development, while impulsivity can be modulated throughout adulthood. Furthermore, CaMKIIa-mediated forebrain knockdown results in aggressive, but not impulsive, behavior. Overall, our data indicate that the 5-HT1BR mediates aggressive and impulsive behavior through modulation of distinct circuits at different times. :tetO1B +/+ (G), and ePet-Cre + ::tetO1B +/+ (J) mice. Cartoons of brains illustrate regions of 5-HT1BR mRNA, including cortex (ctx), dorsal striatum (str), hippocampus (hpc), hypothalamus (hyp), thalamus (thal), substantia nigra (sn), raphe, and cerebellum (cb). Regions of mRNA knockdown are indicated for each manipulation by a lack of shading. Middle: receptor autoradiographs show heat map distribution of 125 I-cyanopindolol receptor binding in three representative coronal sections throughout the brain, rostral at bregma +0.5 mm, mid at bregma À2.3 mm, caudal at bregma À3.5 mm for tetO1B +/+ (B), b-actin- Figure S1 .
RESULTS

Generation and Characterization of Tissue-Specific and Conditional 5-HT1BR Transgenic Mouse
Insertion of the floxed tetO1B cassette (tet operator and htr1b cDNA) in place of the endogenous htr1b gene did not alter baseline expression of 5-HT1BR in the brain ( Figures 1A-1C , S1A-S1C, and S1E; F 1,6 = 0.01, p > 0.05). Crossing tetO1B mice to b-actin-tTS mice (henceforth referred to as b-actin-tTS mice) (Mallo et al., 2003) yielded mice with ubiquitous knockdown of 5-HT1BR ( Figure 1D ). Throughout life, these mice had an absence of all receptor binding throughout the brain ( Figures  1E, 1F , S1D, and S1F; tTS À versus tTS + : F 1,6 = 58.92, p < 0.001; tTS + versus zero: t 83 = 0.66, p > 0.05). For tissue-specific knockdown, tetO1B mice were crossed to CaMKIIa-tTS mice (Richardson-Jones et al., 2011) to assess the contribution of heteroreceptors. CaMKIIa-tTS + ::tetO1B +/+ (henceforth referred to as CaMKII-tTS + ) mice showed postnatal knockdown of the expression of one subset of forebrain receptors in the striatum, hippocampus, and cortex ( Figure 1G ). This resulted in a decrease of 5-HT1BR binding in the striatum, hippocampus, cortex, substantia nigra, subthalamic nucleus, olfactory tubercle, and globus pallidus by postnatal (PN)21 ( Figures 1H, 1I , S1G, S1H, and S3C; F 1,6 > 10.90, p < 0.05). 5-HT1BR binding was unaffected in other brain regions measured that represent the remaining population of 5-HT1B heteroreceptors ( Figure S1G ; F 1,6 = 0.51, p > 0.05). These results demonstrate the ability to spatially regulate 5-HT1BR expression in the tetO1B mice. TetO1B mice were also crossed to mice expressing the ePetCre transgene (Scott et al., 2005 ) (B6.Cg-Tg(Fev-cre)1Esd/J, stock 012712; Jackson Laboratory). ePet-Cre::tetO1B +/+ mice (henceforth referred to as ePet-Cre mice) had normal 5-HT1BR expression in all brain regions as measured by receptor autoradiography (F 1,6 = 0.19, p > 0.05); however, any differences in receptor binding in ePet-Cre + mice were likely obscured due to the fact that autoreceptors are distributed widely at relatively low density throughout brain regions that also contain high expression of heteroreceptors ( Figure 1J ). To determine the extent of autoreceptor knockdown, 5-HT1BR mRNA was assessed in the raphe. The number of 5-HT1BR mRNA positive cells was reduced in the raphe ( Figure 1K ; F 1,6 = 44.30, p < 0.001), but not other brain regions ( Figure 1L ), of ePet-Cre + mice. Because some mRNA expression remained in the raphe, we confirmed the functional effect of autoreceptor knockdown using serotonin microdialysis ( Figure S1I ; t 20 = 4.69, p < 0.001).
Receptor expression was also regulated temporally in b-actintTS mice by administering doxycycline in the food. Whole-life administration of doxycycline to b-actin-tTS + mice resulted in rescue of the receptor throughout the brain (Figures 2A, S2A , and S2B; b-actin-tTS + with doxycycline versus tTS À with doxycycline: F 1,6 = 0.10, p > 0.05). Additionally, administration of doxycycline beginning in adulthood rescued receptor Figure 3A ), which is consistent with the phenotype seen in constitutive 5-HT1B KO mice (Saudou et al., 1994) . All pairs of b-actin-tTS + mice (six out of six) displayed aggressive behavior, while only one pair of tTS À mice showed aggression ( Figure 3B ; c 2 1 = 8.57, p < 0.01). b-actin-tTS + duration of aggression was also increased-on average displaying aggressive behaviors including mounting, tail rattling, and/or biting attacks for over a minute out of the 5-min session ( Figure 3C ; F 1,10 = 25.13, p < 0.05). Compared to controls, the number of attacks was also increased in b-actin-tTS + mice ( Figure S4A ; F 1,10 = 8.31, p < 0.05). Their latency to attack was also significantly lower (Figure The inability to rescue the normal phenotype with adult rescue of the receptor was noteworthy, given pharmacology studies that show that activation of 5-HT1BRs with agonists (e.g., ''serenics'') reduce adult aggressive behavior in mice (Fish et al., 1999) . To address this, CP-94,253, a 5-HT1BR-specific agonist, was injected intraperitoneally (i.p.) into b-actin-tTS + mice with adult rescue of the receptor. CP-94,253 injection reduced aggression in mice with adult rescue of the receptor, compared to vehicle injection, in number of pairs attacking ( Figure S4H ; c 2 1 = 9.60, p < 0.01) and number of attacks ( Figure S4I ; F 1,14 = 16.9, p < 0.01). There was no significant reduction in aggression in CP-94,253-treated b-actin-tTS + mice without rescue of 5-HT1BR expression (F 1,14 = 0.121, p > 0.05), suggesting that the effect of CP-94,253 on aggression was specific to 5-HT1BRs. These data demonstrate that the adult-rescued 5-HT1BRs are functional and also highlight that there are distinct adult and developmental effects of 5-HT1BR on mouse aggression. Early postnatal rescue of 5-HT1BR expression was able to reverse the aggressive phenotype in b-actin-tTS + mice. Administration of doxycycline beginning at PN0, but not at PN7, prevented the development of adult aggression ( Figure 3B ). Specifically, following administration of doxycycline beginning at PN0, there was no significant difference between genotypes in the percent of pairs showing aggression (c 2 1 = 0.41, p > 0.05) nor in the time spent engaging in aggressive behaviors ( Figure 3C ; F 1,8 = 3.23, p > 0.05). Conversely, when doxycycline administration began at PN7, b-actin-tTS + mice showed elevated aggression compared to b-actin-tTS À controls ( Figure 3B ; c 2 1 = 6.20, p < 0.05 for PN7). Since rescue of receptor expression led to normal expression levels by 21 days after the start of doxycycline administration ( Figure S3C ), these data suggest a sensitive period of approximately PN21-PN28 for the development of aggressive behavior.
Further localizing the 5-HT1BR subpopulation(s) subserving aggressive behavior, we found that knockdown of postnatal forebrain heteroreceptors using CaMKII-tTS + mice resulted in increased aggressive behavior. Specifically, more CaMKII-tTS + pairs were aggressive compared to CaMKII-tTS À pairs (Figure 3D ; 11 of 14 for tTS + versus 3 of 11 for tTS À ; c 2 1 = 6.58, p < 0.05). Additionally, CaMKII-tTS + mice spent more time on average engaging in aggressive behavior-consisting mostly of tail rattling and biting attacks (Figures 3E and S4C ; F 1,23 = 7.60, p < 0.05)-and also had a shorter latency to attack (Figure S4D ; c 2 1 = 13.44, p < 0.001). Whole-life treatment with doxycycline reduced the aggression in CaMKII-tTS + mice to control levels ( Figure 3D ; c 2 1 = 0.42, p > 0.05) and lengthened the latency to attack ( Figure S4D ; c 2 1 = 0.25, p > 0.05). The time course of the CaMKII-tTS-mediated knockdown (see Figure S3C ) was consistent with the sensitive period suggested from the b-actin-tTS studies above. Specifically, the majority of forebrain heteroreceptor knockdown in CaMKII-tTS + mice was achieved by PN21, with the full extent of knockdown by PN28. Taken together, these data suggest that expression of forebrain heteroreceptors during the pubertal period is important for the development of male aggression. Figure 3F ; c 2 1 = 0.25, p > 0.05), ruling out effects of the transgene insertion on aggression in this paradigm. Additionally, there were no significant differences in the time spent engaging in aggressive behaviors (Figure 3G ; F 1,13 = 0.45, p > 0.05), number of attacks ( Figure S4E ; Impulsive Behavior in the DRL Is Mediated by Adult Expression of 5-HT1BRs Two operant behavior paradigms were used to measure two aspects of impulsivity. The first, a differential reinforcement of lowrate responding (DRL) paradigm, reinforced the ability of a mouse to refrain from responding for a set time period. For example, in a DRL-36 paradigm, mice only receive a reward following a lever press if the lever press was preceded by 36 s of no lever pressing ( Figure 4A ). Wholebrain knockout of the 5-HT1BR in b-actin-tTS + mice resulted in deficits in the DRL task, indicating a more impulsive phenotype, as seen in the constitutive 5-HT1BR knockout (Pattij et al., 2003 Figure S5C ). This resulted in an increased number of non-rewarded lever presses and therefore a significantly higher response-to-reward ratio in b-actin-tTS + mice ( Figure 4C ; F 1,28 = 11.89, p < 0.05). Finally, a Gaussian function was fitted to the non-burst response distribution and revealed a significantly earlier peak responding latency in b-actin-tTS + mice compared to b-actin-tTS À controls, whose peak responding was nearly 10 s later ( Figure S5D ; F 1,28 = 23.04, p < 0.05). The poor performance of the b-actin-tTS + mice in the DRL paradigm was not likely due to a lack of learning, since the peak of the response distribution increased as the target wait time was increased during training ( Figure S5B ). In fact, the number of sessions required to meet criterion in lever pressing acquisition was lower in b-actin-tTS + mice, suggesting no deficit in overall operant learning (F 1,28 = 4.91, p < 0.05). Additionally, there were no significant differences in the number of head entries into the reward receptacle ( Figure S5E ; F 1,28 = 1.81, p > 0.05). A control experiment ruled out an effect of the tTS transgene insertion on DRL behavior, as the behavior of b-actintTS + mice treated with doxycycline throughout life was not significantly different from that of littermate control b-actin-tTS À mice ( Figures S5K-S5P ). Overall, these data confirmed a role for 5-HT1BRs in regulating impulsivity. Interestingly and unexpectedly, the impulsive phenotype was fully recovered with adult rescue of 5-HT1BR, differentiating it from the aggressive phenotype. Doxycycline treatment beginning in adulthood (PN60) resulted in no significant genotype differences between b-actin-tTS À and b-actin-tTS + mice in any parameter analyzed from the DRL paradigm ( Figures S5F-S5J) . Specifically, burst and non-burst responding in b-actin-tTS + mice were normalized to control levels ( Figure 4D ; Figure S5H ), and there were no significant differences between genotypes in the ratio of lever presses to rewards earned ( Figure 4E ; F 1,26 = 0.05, p > 0.05). The means of the fitted curves were not significantly different for b-actin-tTS À and b-actin-tTS + mice treated with doxycycline ( Figure S5I ; F 1,26 = 0.02, p > 0.05). Taken together with the data from the aggression assays, adult rescue of 5-HT1BRs resulted in aggressive, but not impulsive mice. This dissociates the impulsive phenotype from that of aggression and suggests different sensitive periods of serotonergic modulation. The contribution of 5-HT1B autoreceptors and forebrain heteroreceptors to the impulsive phenotype was also assessed in the DRL operant paradigm. Neither CaMKII-tTS + nor ePet-Cre + mice were more impulsive than their littermate controls ( Figures 5 and S6A-S6J ). There were no significant genotype differences in the number of burst lever presses ( Figure 5A , F 1,11 = 1.82, p > 0.05 for CaMKII-tTS; Figure 5C , F 1,16 = 0.93, p > 0.05 for ePet-Cre), or in the distribution of lever press latencies (F 1,11 = 2.48, p > 0.05 for CaMKII-tTS; F 1,16 = 0.34, p > 0.05 for ePet-Cre). The cumulative distribution functions of individual animals showed largely overlapping response curves for both CaMKII-tTS + and ePet-Cre + mice compared to their littermate controls ( Figures S6C and S6H) . Lastly, there were no significant differences in the ratio of lever presses to rewards earned (Figure 5B , F 1,11 = 3.21, p > 0.05 for CaMKII-tTS; Figure 5D , F 1,16 = 0.06, p > 0.05 for ePet-Cre), nor in the means of the curves fitted to lever press response distributions (Figures S6D and S6I Figures  S6K-S6V ). Compared to the results from the aggression studies, the data again suggest a dissociation of aggressive and impulsive behaviors, with forebrain heteroreceptor knockdown resulting in increased aggression, but not impulsivity.
Impulsive Behavior in the Go/No-Go Task Is Mediated by Adult Expression of 5-HT1BRs
To extend the behavioral differences seen in the DRL paradigm, a second operant behavioral task measuring impulsivity was used. A mouse model of the Go/No-Go paradigm adapted from previous studies (McDonald et al., 1998) rewarded the ability to refrain from responding during specific trials. Mice were presented with ''Go'' trials, in which lever presses were rewarded, and ''No-Go'' trials, in which an absence of lever pressing was rewarded (Figure 6A) . b-actin-tTS + mice were more impulsive than b-actintTS À littermate controls, and the behavioral deficit was ameliorated with doxycycline treatment in adulthood. Specifically, in the absence of doxycycline, b-actin-tTS + mice were more impulsive across all trials compared to b-actin-tTS À controls as indexed by the number of correct No-Go trials subtracted from the number of correct Go trials ( Figure 6B ; F 1,27 = 14.29, p < 0.001). Broken down by trial type, b-actin-tTS + mice earned more rewards during Go trials ( Figure S7A ; F 1,27 = 7.75, p < 0.01) and fewer rewards during No-Go trials ( Figure S7B ; F 1,27 = 11.63, p < 0.005) compared to b-actin-tTS À mice. Over the 12 sessions, while both genotypes decreased their impulsivity index, the decrease was greater in b-actin-tTS À mice (genotype 3 session interaction: F 11,297 = 3.03, p < 0.001). During the 12 th session, b-actin-tTS + mice had significantly more false alarms (unrewarded No-Go trials), averaging over 60%, compared to b-actin-tTS À mice, who had a 36% false alarm rate (F 1,27 = 5.58, p < 0.05). Increasing the duration of the NoGo trials from 5 s to 10 s resulted in decreases in the performance of both genotypes, as measured by impulsivity index. However, b-actin-tTS À mice were able to recover their performance within 3 days, while b-actin-tTS + mice were not ( Figure 6B ; F 2,54 = 4.65, p < 0.05). These deficits in the performance of b-actin-tTS + mice in the Go/No-Go task suggested an impulsive phenotype, consistent with results from the DRL paradigm.
To confirm that the poor performance seen in the b-actin-tTS + mice in the Go/No-Go task was due to an impulsive phenotype rather than a deficit in the ability to learn the trial cues, a control experiment assessed cue-based learning. In this task, the cues that signaled Go and No-Go trials were used to signal left-lever or right-lever trials, and as such, all trials required a response ( Figure S7C ). The number of correct trials, represented by the number of rewards earned, was not different between genotypes ( Figure S7D ; F 1,27 = 2.27, p > 0.05). This suggests that the inability to withhold responses during No-Go trials was not due to a deficit in cue-learning. Adult 5-HT1BRs Regulate Dopamine Levels in the Nucleus Accumbens Given the importance of dopamine in modulating impulsive behavior (Cole and Robbins, 1989; Pattij et al., 2007) , we measured dopamine (DA) levels in our knockdown mice. To determine the effects of 5-HT1BR expression on CNS DA levels, microdialysis was performed in the nucleus accumbens (NAc) and dorsal striatum following peripheral injection of GBR 12090, a DA transporter (DAT) blocker ( Figures S8C and S8D ). There was a main effect of 5-HT1BR expression on DA levels in the NAc ( Figure . These results suggest that adult expression of 5-HT1BR regulates NAc DA levels. In contrast, there were no significant effects of 5-HT1BR expression on levels of DA in the dorsal striatum, as previously reported (Shippenberg et al., 2000) ( Figure 7B ; F 3,32 = 1.53, p > 0.05). There were also no group differences in the baseline levels of DA in the NAc or dorsal striatum ( Figure S8A , NAc: F 3,32 = 1.60,p > 0.05; Figure S8B , dorsal striatum: F 3,32 = 1.66, p > 0.05). These data indicate that 5-HT1BRs regulate DA release in the NAc during adulthood, which may be a mechanism by which 5-HT1BRs affect impulsivity.
DISCUSSION
The development of a tissue-specific and temporally conditional 5-HT1BR mouse model allowed us to investigate the contribution of serotonin signaling to the neural circuits underlying aggression and impulsivity (Figure 8 ). First, we showed that aggressive behavior is mediated by the developmental expression of 5-HT1B heteroreceptors. Specifically, whole-life, whole-brain knockdown of 5-HT1BRs resulted in increased aggressive behavior, in agreement with our previous results using constitutive knockouts (Saudou et al., 1994) . Consistent with the presence of a developmental sensitive period, rescue of 5-HT1BR expression in early post-natal development, but not in adulthood, ameliorated the aggressive behavior. Furthermore, forebrain heteroreceptors located on CaMKII-expressing cells mediated this aggressive phenotype, while a reduction in autoreceptors did not modulate aggression. In contrast, the data show a different pattern for the modulation of impulsive behavior. Using two operant conditioning paradigms (DRL and Go/NoGo), mice that lacked all 5-HT1BRs were unable to withhold lever pressing responses, suggesting heightened impulsivity. Interestingly, this impulsive phenotype was fully reversed by rescue of receptor expression in adulthood. Similar to aggression, knockdown of 5-HT1B autoreceptors did not affect impulsive behavior. However, unlike in aggression, forebrain 5-HT1BRs located in CaMKII-expressing cells did not mediate impulsive behavior. Since CaMKII-tTS + cells represent only a subset of 5-HT1B heteroreceptor-containing neurons, these data suggest that a different set of 5-HT1B receptors, located on either non-CaMKII + neurons, neurons in regions not knocked down by our CaMKII-tTS line (e.g., lateral septum, hypothalamus, VTA), or even non-neuronal cells are involved in modulating impulsivity compared to aggressive behavior. Overall, the data presented here support the claim that serotonin can affect aggression and impulsivity through distinct circuits and during different time periods by acting through 5-HT1BRs. We have discovered a developmental sensitive period during which serotonin affects later-life adult aggressive behavior. Many studies in both humans and animal models now support the idea that there are specific periods of development during which genetic and environmental perturbations can influence adult phenotypes related to psychiatric disorders, including anxiety, depression, aggression, and antisocial personality disorder (Ansorge et al., 2004; Caspi et al., 2002 Caspi et al., , 2003 Dodge et al., 1990; Richardson-Jones et al., 2011) . Aggressive behavior has been linked to developmental alterations in monoamine levels through disruptions in monoamine oxidase A (MAOA) activity. A genetic null mutation in the gene encoding MAOA results in increased aggressive and antisocial behavior (Brunner et al., 1993) . A less severe reduction in MAOA activity caused by a variable number tandem repeat polymorphism in the MAOA promoter is associated with conduct disorder and antisocial behavior when coupled with childhood maltreatment (Caspi et al., 2002) . Lastly, an MAOA KO mouse model displays increased aggressive behavior, which correlates with altered developmental levels of serotonin and norepinephrine (Cases et al., 1995) . Other recent studies have implicated dopaminergic signaling during development in the generation of aggressive behavior in rodents. Specifically, blockade of dopamine reuptake in mice during a postnatal period (PN22-PN41) resulted in increased adult aggression (Yu et al., 2014) . Furthermore, aggression in hamsters induced by adolescent administration of cocaine was ameliorated by co-administration of paliperidone, a D2/5-HT2A receptor antagonist (Schwartzer et al., 2009 ). This study implicates the middle of adolescence as the sensitive period for dopaminergic and serotonergic effects on aggression. The sensitive periods reported in these studies are consistent with the sensitive period that we approximate from our data. Both the time course of the doxycycline studies in b-actin mice (taking into account the 21-day lag in complete rescue of receptor expression; see Figure S3A) and the developmental time course of CaMKII promoter activity (see Figure S3C ), suggest that the period encompassing postnatal days PN21-PN28 is important for the maturation of neural circuits underlying adult aggressive behavior. However, given the slow kinetics of the doxycycline effect on receptor expression, other tools will be required to accurately define this sensitive period further. This proposed sensitive period corresponds with the onset of adolescence, which is also the onset of play behavior, the development of social hierarchies, and the appearance of aggressive behavior (Bartolomucci et al., 2004; Pellis and Pasztor, 1999; Terranova et al., 1998) . The developmental, rather than adult, mechanism of action of 5-HT1BRs on aggression shown here, is dissociated from pharmacological data showing that activation of 5-HT1BRs with agonists such as the serenics reduces aggressive behavior when administered in adulthood (Mos et al., 1992; Sijbesma et al., 1991) . The disconnect between knockout and pharmacological phenotypes has been previously identified with regards to 5-HT1BR signaling (Castanon et al., 2000) , but the lack of conditional knockouts prevented investigation into compensatory and/or developmental contributions to these effects. Here, we show a developmental contribution of the receptor to adult aggressive behavior, which seems to be distinct from the 5-HT1BR-mediated pharmacological effects on adult aggression. This dissociation is suggested by the fact that aggression in the adult rescue mice could still be attenuated with acute administration of a 5-HT1BR agonist. One possible explanation is that there could be two populations of 5-HT1BRs that modulate aggression circuits at different developmental time points. Also, although we show here that knocking out 5-HT1BRs in CaMKII + cells is sufficient to generate an aggressive phenotype, it is still possible that other 5-HT1BRs are involved. Specifically, 5-HT1BRs are located in a number of other brain regions implicated in aggression including the periaqueductal gray, ventromedial hypothalamus, and lateral septum (Lin et al., 2011; Siegel et al., 1999; Simon et al., 1998) . Adult expression of one of these populations of receptors may also modulate aggressive behavior. Another possibility is that serenics are affecting aggression in adulthood indirectly through another mechanism, such as reducing impulsivity. Finally, our data do not rule out the possibility that 5-HT1BRs affect different facets of aggressive behavior at different time points. Specifically, our paired aggression assay could be measuring aggression-eliciting factors, rather than or in addition to offensive aggressive behavior directly. Unlike aggressive behavior, impulsive behavior is mediated by the expression of 5-HT1BRs during adulthood. This was not predicted given the impulsive aggression seen in the 5-HT1BR KOs and the frequent co-occurrence of these behavioral phenotypes. Specifically, using the DRL and Go/No-go paradigms, we measured impulsive action, a concept that includes behavioral inhibition and is characterized by the inability to inhibit a response. This type of impulsivity may be dissociated from impulsive choice, which represents intolerance to delays and is frequently measured in delayed discounting tasks (Bari and Robbins, 2013; Broos et al., 2012) . Evidence suggests that 5-HT1BRs affect impulsive action (Pattij et al., 2003) , but may not affect impulsive choice (Brunner and Hen, 1997) . This is important because these two aspects of impulsivity are thought to be mediated by distinct circuits and may contribute to different psychiatric disorders (Dalley et al., 2011; Robbins et al., 2012) . For example, deficits in impulsive action predict substance abuse potential and severity of pathological gambling (Brevers et al., 2012; Loos et al., 2009) , while deficits in impulsive choice may play a larger role in attention deficit hyperactivity disorder (ADHD) (Solanto et al., 2001; Sonuga-Barke, 2003) . Interestingly, studies have implicated 5-HT1BR expression levels and polymorphisms in substance use disorders and pathological gambling (Cao et al., 2013; Potenza et al., 2013; Proudnikov et al., 2006; Rocha et al., 1998) . Our findings suggest that different pharmacological approaches may be necessary depending on the type of inhibitory control or impulsivity (or impulsivities) associated with each disorder.
The relationship between serotonin signaling and impulsive behavior is complex. On one hand, studies show that impulsive behavior is negatively correlated with serotonin levels (Fairbanks et al., 2001; Harrison et al., 1997) , and activation of serotonin neurons or serotonin receptors reduces impulsivity (Evenden, 1999; Miyazaki et al., 2014) . However, other evidence suggests that increased serotonin levels in the prefrontal cortex are associated with increases in impulsivity (Dalley et al., 2002) , suggesting potential brain region-specific effects. Additionally, activation of different serotonin receptors can have opposing effects on impulsive behavior (Winstanley et al., 2004) . Finally, recent evidence suggests that dorsal raphe serotonin neurons also release glutamate that can have behavioral effects similar to that of serotonin (Liu et al., 2014) . Although 5-HT1BR knockouts have increased serotonin levels (Gardier et al., 2003; Malagié et al., 2001) , it remains unclear whether this change in serotonin signaling plays a role in modulating impulsivity. Here, we show that knocking down 5-HT1B autoreceptors is not sufficient to change impulsive behavior; however, our significant but incomplete knockdown still leaves open the possibility for the remaining autoreceptors to be involved in the behavioral effects of 5-HT1BR knockout. Another possibility is that changes in serotonergic tone via 5-HT1B autoreceptors contribute to increased impulsivity only in conjunction with the absence of certain 5-HT1BR heteroreceptors. In such a situation, knockdown of both autoreceptors and another population of 5-HT1B heteroreceptors would be necessary to elicit increased impulsive behavior. One potential scenario leading to impulsivity could therefore be an interaction of increased serotonergic tone coupled with increased dopamine levels, as is supported by the fact that depletion of serotonin with 5,7-dihydroxytryptamine results in an attenuation of amphetamine-induced premature responding (Harrison et al., 1997) . Similarly, serotonin signaling could interact with dopamine to affect impulsivity. Consistent with our results, there is evidence to support a role for NAc DA levels in the regulation of impulsive action. Local injection of amphetamine into the NAc increases premature responding, suggesting a lack of behavioral inhibition or increased impulsive action (Cole and Robbins, 1987) . These effects could be blocked by a D2 receptor antagonist and were not affected by lesions of the norepinephrine system, suggesting a dopaminergic action of amphetamine on impulsivity (Pattij et al., 2007) . Although 5-HT1BRs may affect impulsive action via dopamine in the NAc, there are many other potential mechanisms for these effects. Dopamine signaling in a number of brain regions, not limited to the NAc, has been linked to impulsivity and could be involved in 5-HT1BR modulation of impulsive action. For example, levels of dopamine and dopamine receptors in the PFC are correlated with increased impulsive action (Bari and Robbins, 2013; Counotte et al., 2009; Moon et al., 2014) . Additionally, other neurotransmitters and neuromodulators play an important role in modulating impulsive action. For example, increasing norepinephrine levels results in increased impulsivity (Swann et al., 2005 (Swann et al., , 2013 and increased levels of both vasopressin and neuropeptide Y are associated with increased impulsive behavior (Aliczki et al., 2014; Coccaro et al., 2012) . Furthermore, even decreased GABA synthesis in the NAc core is sufficient to cause increases in impulsive action (Caprioli et al., 2014) .
Overall, this mouse model of 5-HT1BR-associated deficits in impulse control provides a useful tool for the discovery of new treatments for psychiatric disorders in which impulsivity is a key phenotype. There is a substantial amount of evidence linking 5-HT1BR to impulsivity in humans, and our findings suggest that pharmacologic interventions targeting 5-HT1BR-mediated impulsivity may be effective in adults. Recent haplotype and meta-analyses have confirmed links between 5-HT1BR polymorphisms and heroin, cocaine, and alcohol abuse (Cao et al., 2013; Proudnikov et al., 2006) . Additionally, increased 5-HT1BR binding is correlated with severity of gambling in pathological gamblers (Potenza et al., 2013) . Last, a number of studies including a meta-analysis have found significant associations between 5-HT1BR polymorphisms and ADHD in a number of different populations (Banerjee et al., 2012; Gizer et al., 2009) . Future research will be aimed at investigating the circuits underlying these effects of 5-HT1BR on impulsivity and will hopefully set the stage for pharmacological interventions aimed at decreasing impulsive behavior in disorders such as substance abuse, pathological gambling, and ADHD.
EXPERIMENTAL PROCEDURES
Please see Supplemental Experimental Procedures for full details of methods and reagents.
Mice A vector containing a floxed-tetO-htr1b cDNA-PGK-neo cassette was introduced into the genome through homologous recombination in place of the endogenous htr1b gene coding region ( Figure S1 ). Spatial-and temporal-specific knockdown was achieved through genetic crosses to b-actin-tTS, CaMKII-tTS, and ePet-Cre mice, and by administration of doxycycline to tTS lines. All animal care and testing was approved by the Institutional Animal Use and Care Committee and was in accordance with the NIH's Guide for the Care and Use of Laboratory Animals.
Tissue
For receptor binding and in situ hybridization analysis, mice were sacrificed by cervical dislocation and decapitation. 125 I-cyanopindolol autoradiography for 5-HT1BR localization was performed based on a previously described protocol (Saudou et al., 1994) . In situ hybridization was performed based on the Allen Brain Atlas Protocol using a digoxigenin (DIG)-labeled htr1b cRNA probe previously described (Tanaka et al., 2012) .
Behavior Aggression assays were conducted on male mice at 13-15 weeks of age, using a paired housing procedure in which two mice of the same genotype are co-housed separated by a plexiglas divider, as previously described (Yu et al., 2014) . Operant conditioning studies beginning at 12 weeks of age were conducted in eight identical operant chambers (Med Associates) on food-restricted mice. Following behavioral shaping, DRL and Go/No-Go paradigms were used to test impulsive action.
In Vivo Microdialysis
Samples were collected from the dorsal striatum and nucleus accumbens brain regions of awake and freely moving mice, at baseline conditions and following injection of GBR 12090 or escitalopram. Dialysates were analyzed for DA or 5-HT levels using HPLC.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures and eight figures and can be found with this article online at http://dx.doi. org/10.1016/j.neuron.2015.03.041.
